Edition:
United Kingdom

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.91USD
8:07pm GMT
Change (% chg)

$0.05 (+1.92%)
Prev Close
$2.86
Open
$2.85
Day's High
$2.94
Day's Low
$2.83
Volume
132,565
Avg. Vol
340,238
52-wk High
$3.16
52-wk Low
$2.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.08 December 12 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1 46.08 46.08 46.08 63.05
Quarter Ending Mar-19 1 35.35 35.35 35.35 --
Year Ending Dec-18 2 187.56 199.07 176.05 200.03
Year Ending Dec-19 2 132.26 145.46 119.05 143.10
Earnings (per share)
Quarter Ending Dec-18 1 0.08 0.08 0.08 0.14
Quarter Ending Mar-19 1 0.05 0.05 0.05 --
Year Ending Dec-18 2 -0.55 -0.50 -0.60 0.33
Year Ending Dec-19 2 0.14 0.15 0.13 0.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 50.60 67.90 17.30 34.19
Quarter Ending Jun-18 44.66 46.58 1.92 4.30
Quarter Ending Mar-18 56.90 38.52 18.38 32.31
Quarter Ending Dec-17 45.30 68.04 22.74 50.19
Quarter Ending Sep-17 61.86 62.75 0.89 1.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 46.08 48.10 48.10 48.09 63.05
Quarter Ending Mar-19 35.35 35.40 35.40 -- --
Year Ending Dec-18 187.56 179.93 179.93 179.93 200.03
Year Ending Dec-19 132.26 132.26 132.26 132.18 143.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 0 1
Quarter Ending Mar-19 0 1 0 1
Year Ending Dec-18 1 0 1 0
Year Ending Dec-19 0 0 0 0
Earnings